Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study

Mansour Rezaei1, Negin Fakhri2, Yahya Pasdar3

  • 1Professor of Biostatistics, Biostatistics Department, Social Development and Health Promotion Research Center, Kermanshah University of medical sciences, Kermanshah, Iran.

Insights

Identifying key factors for lipid disorders is crucial for preventing chronic diseases like heart disease. Alkaline phosphatase, Fat Free Mass (FFM) index, and Hemoglobin (HGB) significantly predict blood lipid levels.

Area of Science:

  • Biochemistry and clinical diagnostics
  • Cardiovascular health and disease prevention
  • Data science in healthcare

Background:

  • Lipid disorders are significant risk factors for chronic diseases, particularly Chronic Heart Disease (CHD).
  • Understanding factors influencing dyslipidemia aids in mitigating chronic disease development.
  • This study aimed to model risk factors for dyslipidemia and blood lipid indices.

Purpose of the Study:

  • To identify and model key predictor variables for dyslipidemia.
  • To investigate the relationship between various factors and blood lipid profiles.
  • To provide insights for controlling blood lipid markers and reducing chronic disease risk.

Main Methods:

  • Utilized data from the Ravansar cohort study (2014-16).
  • Employed Artificial Neural Network (ANN) data mining for sensitivity analysis of 453 variables.
  • Used stepwise regression to analyze variable relationships and SPSS software for statistical analysis.

Main Results:

  • 40% of participants had lipid disorders.
  • ANN identified 12 nutrition and physical status-related predictors for dyslipidemia.
  • Alkaline phosphatase, Fat Free Mass (FFM) index, and Hemoglobin (HGB) significantly correlated with all seven blood lipid markers.
  • Waist Hip Ratio showed strong correlation with cholesterol and LDL; FFM index most impacted triglyceride and HDL ratios.

Conclusions:

  • Alkaline phosphatase, FFM index, and HGB are common predictors for all blood lipid markers.
  • Controlling these identified factors is recommended for better management of blood lipid profiles.
  • Findings support targeted interventions to reduce chronic disease risk associated with lipid disorders.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
478
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
748
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
251
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
596